Alerts will be sent to your verified email
Verify EmailSUPRIYA
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Supriya Lifescience Limited is an Indian manufacturer and supplier of APIs, focusing on research and development. They offer a diverse range of niche APIs for different therapeutic segments and have a significant market presence globally.
Supriya Lifescience major competitors are AMI Organics, Aether Industries, Shilpa Medicare, Aarti Pharmalabs, Morepen Laboratories, Aarti Drugs, Solara Active Pharma.
Market Cap of Supriya Lifescience is ₹5,190 Crs.
While the median market cap of its peers are ₹6,319 Crs.
Supriya Lifescience seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | Mar Jun Sep Dec | Jun Sep Dec | ||||||||||||||||
Investor Presentation | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar May Jun Aug Sep Dec | Jan Dec | ||||||||||||||
Conference Call | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Dec | ||||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|